ArticleSleep2026
Tricyclic antidepressants suppress sleep in Caenorhabditis elegans.
Article in Sleep, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
STUDY
objectivesSleepiness and fatigue are common symptoms during illness and may persist after the resolution of illness. To gain insight into the neurochemistry of sickness-induced sleep and to discover therapeutic candidates, we performed a high throughput chemical screen using the animal model Caenorhabditis elegans.
methodsWorms were irradiated with ultraviolet light to induce sickness and then transferred to wells of a 96-well plate each containing a different bioactive chemical dissolved in an aqueous solution. The fraction of quiescent animals was assessed via stereomicroscopic observation. We performed 12 vehicle-only controls for each 96-well plate and considered sleep-inhibiting chemicals as those with a fraction quiescent at least 3 standard deviations less than controls. We followed up the screen with dedicated mechanistic studies of the drug amitriptyline.
resultsAmong 3683 bioactive chemicals screened, 42 strongly reduced sleep behavior. We retested 26 and replicated 23 chemicals as sleep-disrupting. Among replicated compounds were amitriptyline (AMI) and other tricyclic anti-depressants (TCAs). AMI acted downstream of or in parallel to activation of sleep-promoting neurons. In addition to suppressing sleep in sickness (SIS), AMI also suppressed sleep in health and reduced survival. We tested and rejected the hypothesis that AMI acts by increasing monoaminergic tone, providing evidence that TCAs act via a novel mechanism to block sleep.
conclusionsThis is the first high-throughput screen for chemicals modulating SIS. Elucidating the mechanism by which AMI and other chemicals regulate sleep will lead to new biological insights regarding the mechanisms of sleep.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.